We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$393M
AUM Growth
+$20.1M
Cap. Flow
+$9.32M
Cap. Flow %
2.37%
Top 10 Hldgs %
14.62%
Holding
983
New
387
Increased
109
Reduced
91
Closed
395

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$12.3M
2
MRNA icon
Moderna
MRNA
+$5.95M
3
QCOM icon
Qualcomm
QCOM
+$4.24M
4
TAL icon
TAL Education Group
TAL
+$3.82M
5
AMD icon
Advanced Micro Devices
AMD
+$3.65M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$3.44M
2
KMB icon
Kimberly-Clark
KMB
+$2.7M
3
MCO icon
Moody's
MCO
+$2.68M
4
UPS icon
United Parcel Service
UPS
+$2.64M
5
SHW icon
Sherwin-Williams
SHW
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 17.91%
2 Technology 17.83%
3 Consumer Discretionary 11.15%
4 Industrials 9.32%
5 Materials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$161B
$1.79M 0.46%
25,993
+14,181
+120% +$947K
TSM icon
27
TSMC
TSM
$2.09T
$1.76M 0.45%
14,610
+7,870
+117% +$922K
CTAS icon
28
Cintas
CTAS
$82.4B
$1.74M 0.44%
+18,196
New +$1.61M
ALGN icon
29
Align Technology
ALGN
$12B
$1.73M 0.44%
2,823
+1,672
+145% +$990K
GEN icon
30
Gen Digital
GEN
$15.6B
$1.68M 0.43%
+61,584
New +$1.53M
CERN
31
DELISTED
Cerner Corp
CERN
$1.63M 0.41%
+20,883
New +$1.61M
PENN icon
32
PENN Entertainment
PENN
$2.74B
$1.57M 0.4%
+20,553
New +$1.77M
NFLX icon
33
Netflix
NFLX
$292B
$1.57M 0.4%
+29,700
New +$1.52M
AVTR icon
34
Avantor
AVTR
$7.81B
$1.57M 0.4%
+44,151
New +$1.43M
IFF icon
35
International Flavors & Fragrances
IFF
$19.4B
$1.56M 0.4%
+10,426
New +$1.5M
OXY icon
36
Occidental Petroleum
OXY
$57B
$1.55M 0.39%
+49,469
New +$1.33M
SLB icon
37
SLB Ltd
SLB
$77.8B
$1.54M 0.39%
+48,275
New +$1.48M
CVS icon
38
CVS Health
CVS
$137B
$1.54M 0.39%
18,469
-48
-0.3% -$3.93K
LOW icon
39
Lowe's Companies
LOW
$116B
$1.53M 0.39%
7,913
+1,484
+23% +$290K
CL icon
40
Colgate-Palmolive
CL
$72.6B
$1.53M 0.39%
+18,815
New +$1.54M
WMB icon
41
Williams Companies
WMB
$90.5B
$1.49M 0.38%
56,269
+47,637
+552% +$1.22M
DHI icon
42
D.R. Horton
DHI
$41B
$1.44M 0.37%
+15,953
New +$1.5M
MSFT icon
43
Microsoft
MSFT
$2.84T
$1.42M 0.36%
5,247
-5,852
-53% -$1.49M
ZM icon
44
Zoom
ZM
$25.8B
$1.41M 0.36%
+3,652
New +$1.22M
TEAM icon
45
Atlassian
TEAM
$22B
$1.39M 0.35%
+5,409
New +$1.27M
BMY icon
46
Bristol-Myers Squibb
BMY
$127B
$1.38M 0.35%
20,582
+4,764
+30% +$311K
LPX icon
47
Louisiana-Pacific
LPX
$5.2B
$1.37M 0.35%
+22,772
New +$1.46M
HII icon
48
Huntington Ingalls Industries
HII
$11.3B
$1.36M 0.34%
+6,435
New +$1.37M
OVV icon
49
Ovintiv
OVV
$17.5B
$1.36M 0.34%
43,064
+34,480
+402% +$926K
WELL icon
50
Welltower
WELL
$178B
$1.35M 0.34%
+16,266
New +$1.25M

Similar funds

Y-Intercept (HK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Y-Intercept (HK) held 983 positions worth $393M, up 5.4% from $373M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Y-Intercept (HK)'s Q2 2021 filing shows 387 new, 109 increased, 91 reduced and 395 closed positions. Its largest new stake was Linde: 42,339 shares worth $12.2M. The largest sale was Baidu, an estimated $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Y-Intercept (HK)'s largest Q2 2021 buy was Linde: 42,339 shares worth $12.2M.
  • Y-Intercept (HK) added most to Moderna in Q2 2021, an estimated $5.95M increase.
  • Y-Intercept (HK)'s biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $2.59M.
  • Y-Intercept (HK) fully exited Baidu in Q2 2021, selling an estimated $3.44M.
  • Y-Intercept (HK)'s ten largest holdings make up 15% of its $393M portfolio in Q2 2021.
  • Y-Intercept (HK) opened 387 new positions and closed 395 in Q2 2021.
  • Y-Intercept (HK)'s portfolio value rose 5.4% quarter-over-quarter to $393M.

Based on Y-Intercept (HK)'s 13F filing for Q2 2021, filed 12 Aug 2021.